Olanzapine Impurity 13 | CAS 1070876-09-3 - Request Quote
Olanzapine Impurity 13
| SZ CAT No: | SZ-O001034 |
| CAS No | 1070876-09-3 |
| Mol.F. | C28H26N6S2 |
| Mol.Wt. | 510.7 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Olanzapine Impurity 13 is chemically 1,4-Bis(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazine. Olanzapine Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Olanzapine Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Olanzapine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1070876-09-3
Purchase 1070876-09-3
Order 1070876-09-3
Enquire 1070876-09-3
price of 1070876-09-3
1070876-09-3 Supplier
1070876-09-3 Manufacturer
1070876-09-3 Exporter
buy high quality Olanzapine Impurity 13
Purchase Olanzapine Impurity 13
Olanzapine Impurity 13 suppliers
Olanzapine Impurity 13 manufacturers
Olanzapine Impurity 13 price
Order Olanzapine Impurity 13
Enquire Olanzapine Impurity 13
Olanzapine Impurity 13 cost
Olanzapine Impurity 13 Supplier
Olanzapine Impurity 13 Distributor
Olanzapine Impurity 13 for Method Validation
Olanzapine Reference Standard
Olanzapine Impurity 13 for ANDA Filing
Olanzapine Impurity 13 for Forced Degradation Studies
Olanzapine Impurity 13 Identification Standards
Olanzapine Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.